Projects per year
Fingerprint
Dive into the research topics where Niels Vandewalle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
ANI400: The evaluation of AXL-specific single domain antibodies as diagnostic tracer and therapeutic application in Acute Myeloid Leukemia
De Veirman, K. (Administrative Promotor) & Vandewalle, N. (CoI (Co-Promotor))
1/11/24 → 30/04/25
Project: Fundamental
-
FWOSB110: Nanobody-based individualized AXL targeting to reverse immune suppression and overcome therapy resistance in Acute Myeloid Leukemia
Vandewalle, N. (Administrative Promotor) & De Veirman, K. (Administrative Promotor)
1/11/20 → 31/10/24
Project: Fundamental
-
AXL-Specific Single-Domain Antibodies: A Novel Diagnostic and Therapeutic Strategy in PDAC
Denis, A., Michiels, E., Baldan, J., Satilmis, H., Zhan, D., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N., Rooman, I. & De Veirman, K., 6 Feb 2026. 1 p.Research output: Unpublished contribution to conference › Poster
-
AXL-erating the fight: Conquering acute myeloid leukemia with single domain antibodies
Vandewalle, N., 2025, 186 p.Research output: Thesis › PhD Thesis
-
Activated cDCs by anti-CD40 agonist therapy induce anti-tumor effectsin Multiple Myeloma
Verheye, E., Kancheva, D., Satilmis, H., Vandewalle, N., Fan, R., Bardet, P., Clappaert, E., Vanderkerken, K., De Veirman, K. & Laoui, D., 2024, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 30 May 2024, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 1 Feb 2024, (Unpublished).Research output: Unpublished contribution to conference › Poster
Datasets
-
Dataset of AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Vandewalle, N. (Creator), Satilmis, H. (Creator), Verheye, E. (Creator), Wang, Y. (Creator), De Groof, T. (Creator), Bridoux, J. (Creator), Kerre, T. (Creator), De Beule, N. (Creator), De Becker, A. (Creator), De Bruyne, E. (Creator), Menu, E. (Creator), Vanderkerken, K. (Creator), Breckpot, K. (Creator), Devoogdt, N. (Creator) & De Veirman, K. (Creator), Theranostics, 15 Apr 2024
DOI: 10.7150/thno.91456, https://zenodo.org/records/15111364
Dataset
-
A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages
Laoui, D. (Creator), Kancheva, D. (Creator), Satilmis, H. (Creator), Vandewalle, N. (Creator), Fan, R. (Creator), Bardet, P. (Creator), Clappaert, E. (Creator), Verstaen, K. (Creator), De Becker, A. (Creator), Vanderkerken, K. (Creator) & De Veirman, K. (Creator), NCBI Gene Expression Omnibus, 14 Nov 2024
Dataset
Prizes
-
Best Poster Presentation
Vandewalle, N. (Recipient), Menu, E. (Recipient), De Bruyne, E. (Recipient), De Veirman, K. (Recipient), Breckpot, K. (Recipient) & Devoogdt, N. (Recipient), 2 Feb 2024
Prize: Prize (including medals and awards)
Activities
-
AXL-specific Single-Domain Antibodies Modulate the Immune Microenvironment and Enhance Checkpoint Blockade in AML
Zhan, D. (Presenter), Vandewalle, N. (Contributor), Satilmis, H. (Contributor), Verheye, E. (Contributor), De Bruyne, E. (Contributor), Menu, E. (Contributor), Vanderkerken, K. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor) & De Veirman, K. (Contributor)
25 Sept 2025Activity: Talk or presentation › Talk or presentation at a conference
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Vandewalle, N. (Presenter), Satilmis, H. (Contributor), Verheye, E. (Contributor), Wang, Y. (Contributor), De Groof, T. (Contributor), De Beule, N. (Contributor), kerre, T. (Contributor), De Beule, N. (Contributor), De Becker, A. (Contributor), De Bruyne, E. (Contributor), Menu, E. (Contributor), Vanderkerken, K. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor) & De Veirman, K. (Contributor)
12 Mar 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Charity Quiz 2024
Vandewalle, N. (Chair), Wyns, A. (Chair) & Geirnaert, F. (Chair)
6 Dec 2024Activity: Participating in or organising an event › Participating in or organizing a school event
-
PhD Day of the LSM Doctoral School
Geirnaert, F. (Chair), Wyns, A. (Chair) & Vandewalle, N. (Chair)
26 Mar 2024Activity: Participating in or organising an event › Participation in conference
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Vandewalle, N. (Speaker), Meysman, L. (Contributor), De Beule, N. (Contributor), De Becker, A. (Contributor), Satilmis, H. (Contributor), Verheye, E. (Contributor), Fan, R. (Contributor), De Bruyne, E. (Contributor), Menu, E. (Contributor), Vanderkerken, K. (Contributor), Breckpot, K. (Contributor), Devoogdt, N. (Contributor) & De Veirman, K. (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Targeting AXL, by small molecule inhibitors and Nanobody-based approaches, to eliminate cancer cells and improve chemotherapeutic responses in Acute Myeloid Leukemia
De Veirman, K. (Promotor), Devoogdt, N. (Co-promotor), Breckpot, K. (Co-promotor) & Vandewalle, N. ((PhD) Student), 18 Jun 2020Student thesis: Master's Thesis